Suskind Anne M, Saigal Christopher S, Hanley Janet M, Lai Julie, Setodji Claude M, Clemens J Quentin
Department of Urology, University of California, San Francisco, San Francisco, CA.
Department of Urology, University of California, Los Angeles, Los Angeles, CA.
Urology. 2016 Apr;90:50-5. doi: 10.1016/j.urology.2015.11.051. Epub 2016 Jan 26.
To determine the incidence and characteristics of women with uncomplicated recurrent urinary tract infections (UTIs) and to explore whether the use of culture-driven treatment affects rates of UTI-related complications and resource utilization.
Using MarketScan claims from 2003 to 2011, we identified UTI-naive women ages 18-64 with incident-uncomplicated recurrent UTIs. Recurrent UTIs were defined as 3 UTI visits associated with antibiotics during a 12-month period. Cases were excluded if they had a UTI in the preceding year, or if they had any complicating factors (eg, abnormality of the urinary tract, neurologic condition, pregnancy, diabetes, or currently taking immunosuppression). We next assessed use of urine cultures, imaging, and cystoscopy, and performed propensity score matching with logistic regression to determine whether having a urine culture associated with >50% of UTIs affected rates of complications and downstream resource utilization.
We identified 48,283 women with incident-uncomplicated recurrent UTIs, accounting for an overall incidence of 102 per 100,000 women, highest among women ages 18-34 and 55-64. Sixty-one percent of these women had at least 1 urine culture, 6.9% had imaging, and 2.8% had cystoscopy. Having a urine culture >50% of the time was associated with fewer UTI-related hospitalizations and lower rates of intravenous antibiotic use, whereas demonstrating higher rates of UTI-related office visits and pyelonephritis.
The incidence of uncomplicated recurrent UTIs increases with age. Urine culture-directed care is beneficial in reducing high-cost services including UTI-related hospitalizations and intravenous antibiotic use, making urine cultures a valuable component to management of these patients.
确定单纯性复发性尿路感染(UTI)女性的发病率及特征,并探讨采用基于培养结果的治疗方法是否会影响UTI相关并发症的发生率及资源利用情况。
利用2003年至2011年的MarketScan索赔数据,我们确定了年龄在18 - 64岁、初发单纯性复发性UTI的未患UTI女性。复发性UTI定义为在12个月内有3次与抗生素相关的UTI就诊。如果患者上一年患有UTI,或有任何复杂因素(如尿路异常、神经疾病、妊娠、糖尿病或正在接受免疫抑制治疗),则将其排除。接下来,我们评估了尿培养、影像学检查和膀胱镜检查的使用情况,并进行倾向评分匹配及逻辑回归分析,以确定尿培养次数超过UTI次数50%是否会影响并发症发生率及后续资源利用情况。
我们确定了48,283例初发单纯性复发性UTI女性,总体发病率为每10万名女性中有102例,在18 - 34岁和55 - 64岁的女性中发病率最高。这些女性中有61%至少进行了1次尿培养,6.9%进行了影像学检查,2.8%进行了膀胱镜检查。尿培养次数超过50%的时间与UTI相关住院次数减少及静脉使用抗生素率降低相关,而UTI相关门诊就诊和肾盂肾炎发生率较高。
单纯性复发性UTI的发病率随年龄增长而增加。以尿培养为导向的治疗有助于减少包括UTI相关住院和静脉使用抗生素在内的高成本服务,使尿培养成为这些患者管理中的重要组成部分。